Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial

By sjmartinez • September 10, 2024

Masheto G, Brummel SS, Ziemba L, Shepherd J, Mbengeranwa T, Igawa L, Coletti A, Mukura D, Rossouw L, Theron G, Krotje C, Jean-Philippe P, Chakhtoura N, Cassim H, Mathiba SR, Maena J, Murtaugh W, Fairlie L, Currier J, Hoffman R, Chinula L, Sax PE, Stranix-Chibanda L, Lockman S; IMPAACT 2010/VESTED Study Team and Investigators. Markers of Maternal Bone and Renal Toxicity Through 50 Weeks Postpartum: IMPAACT 2010 (VESTED) Trial. J Acquir Immune Defic Syndr. 2024 Oct 1;97(2):172-179. doi: 10.1097/QAI.0000000000003478. PMID: 39250651; PMCID: PMC11384307.

Tags: Infectious Diseases, Publications

Vaccination with mRNA-encoded membrane-anchored HIV envelope trimers elicited tier 2 neutralizing antibodies in a phase 1 clinical trial

Parks KR, Moodie Z, Allen MA, Yen C, Furch BD, MacPhee KJ, Ozorowski G, Heptinstall J, Hahn WO, Zheng Z, Lu H, Grant S, Domin[...]

Mirtazapine reduces hypothetical methamphetamine demand in humans

Rush CR, Santos GM, McMahan VM, Fraser A, Clark J, Luna Marti X, Walker JE, Shoptaw S, Coffin PO. Mirtazapine reduces hypothetical methamphetamine demand in[...]

A systematic nomenclature for mpox viruses causing outbreaks with sustained human-to-human transmission

Ruis C, Lusamaki E, O'Toole A, Otieno JR, Colquhoun R, Roemer C, Wawina-Bokalanga T, Tshiani-Mbaya O, Jansen D, Makangara JC, Agrawal A, Abu-Raddad LJ, Ahuka-Mundeke[...]